Vir Biotechnology Inc (VIR)
- Exchange
- NASDAQ
- Symbol
- VIR
- Sector
- Life Sciences
- Industry
- Biological Products, (no Disgnostic Substances)
- Description
- Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The company is headquartered in San Francisco, California.
- Country
- USA
Stock price
At close: November 5, 2024
-
Open9.33
-
High9.65
-
Low9.20
-
Close9.64
-
Volume1,109,270
Financial ratios
Dec 31, 2023
Activity ratios
Liquidity ratios
Solvency ratios
Profitability ratios
Inventory turnover
—
Receivables turnover
—
Payables turnover
0.44
Working capital turnover
0.06
Days of inventory on hand (DOH)
—
Days of sales outstanding (DSO)
—
Number of days of payables
836.13
Fixed asset turnover
0.90
Total asset turnover
0.04
Current ratio
9.05
Quick ratio
9.29
Cash ratio
9.29
Cash conversion cycle
-836.13
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
1.21
Interest coverage
-1,431.60
Gross profit margin
96.79%
Operating profit margin
-794.04%
Pretax margin
-728.93%
Net profit margin
-713.76%
Operating return on assets (Operating ROA)
-35.66%
Return on assets (ROA)
-32.05%
Return on total capital
-43.03%
Return on equity (ROE)
-38.68%